Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Shu-na Wang"'
Autor:
Zhen Xing, Hong Liu, Yan Sun, Yu-peng Zhang, Xiu-ming Xing, Kai-li Yang, Jun Zhao, Shu-na Wang
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35406- (2024)
Background: This study aimed to evaluate the efficacy of ranibizumab for the treatment of macular edema secondary to branch retinal vein occlusion (BRVO-ME), changes in retinal volume and central retinal thickness (CRT) before and after therapy, and
Externí odkaz:
https://doaj.org/article/0545a27bf4444df48988b34425d6bdc9
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The in-vivo non-human primate animal and in-vitro cell disease models play a crucial part in the study of the mechanisms underlying the occurrence and development of pancreatic diseases, but with increasingly prominent limitations with in-depth resea
Externí odkaz:
https://doaj.org/article/2f9974da633e47f3b7a928c8326c6dcd
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-9 (2023)
Abstract Objective To evaluate the clinical effect of a multidisciplinary collaboration team combined with a palliative care model in patients with terminal cancer. Method A total of 84 patients diagnosed with terminal cancer in our hospital were inc
Externí odkaz:
https://doaj.org/article/2d37d559fe4c42dcbcdd92472e1fa779
Autor:
Liang-Yan Wang, Chao-Qun Liu, Jian-Liang Liu, Lin Lin, Kai-Li Yang, Ya-Nan Mu, Zhao-Guang Zhang, Fan Jia, Shu-Na Wang, Gang Sun
Publikováno v:
Guoji Yanke Zazhi, Vol 20, Iss 12, Pp 2163-2166 (2020)
AIM: To explore the clinical application value of optical coherence tomography angiography(OCTA)in patients with retinal vein occlusion(RVO). METHODS:Retrospective case study. From January 2018 to December 2019, 40 cases with 40 eyes of RVO patients
Externí odkaz:
https://doaj.org/article/37bdd80fbc084a3abc1885bd489ef81a
Autor:
Dao-Xin Wang, Sheng-Li Qing, Zhu-Wei Miao, Heng-Yu Luo, Jia-Sheng Tian, Xiu-Ping Zhang, Shu-Na Wang, Tian-Guang Zhang, Chao-Yu Miao
Publikováno v:
Cells, Vol 12, Iss 4, p 568 (2023)
Nicotinamide phosphoribosyltransferase (Nampt) is the rate-limiting enzyme in the salvage pathway of nicotinamide adenine dinucleotide (NAD) biosynthesis. Thus far, hepatic Nampt has not been extensively explored in terms of its effects on serum lipi
Externí odkaz:
https://doaj.org/article/7d43a471f5244914a41b964957ef55cc
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) with chronic and recurrent characteristics caused by multiple reasons. Although the pathogenic factors have not been clarified yet, recent studies have demonstrated that intestinal microb
Externí odkaz:
https://doaj.org/article/0c1170f3da234b7c94532a9f2b5ed26b
Publikováno v:
Stroke and Vascular Neurology, Vol , Iss
The use of biologics in various diseases has dramatically increased in recent years. Stroke, a cerebrovascular disease, is the second most common cause of death, and the leading cause of disability with high morbidity worldwide. For biologics applied
Externí odkaz:
https://doaj.org/article/80ea9d6f6d8b4d99a91a958b4c34c230
Publikováno v:
Acta Pharmacologica Sinica. 44:513-523
Establishing a stoke experimental model, which is better in line with the physiology and function of human brain, is the bottleneck for the development of effective anti-stroke drugs. A three-dimensional cerebral organoids (COs) from human pluripoten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6179f5bbdeee57ea683212208c8d3353
https://doi.org/10.1038/s41401-022-00986-4
https://doi.org/10.1038/s41401-022-00986-4
Autor:
Tian-ying Xu, Sheng-li Qing, Jing-xin Zhao, Jie Song, Zhu-wei Miao, Jia-xin Li, Feng-yan Yang, Huan-yu Zhao, Si-li Zheng, Zhi-yong Li, Shu-na Wang, Chao-yu Miao
Publikováno v:
Acta Pharmacologica Sinica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fc8e187c7840bbf82e1a52b57d28d49
https://doi.org/10.1038/s41401-023-01090-x
https://doi.org/10.1038/s41401-023-01090-x
Publikováno v:
Neural Regeneration Research; Oct2023, Vol. 18 Issue 10, p2119-2126, 8p